A carregar...
Amphiregulin retains ERα expression in acquired aromatase inhibitor resistant breast cancer cells
Acquired resistance to aromatase inhibitors (AIs) is a significant clinical issue in endocrine therapy for estrogen receptor (ER) positive breast cancer which accounts for the majority of breast cancer. Despite estrogen production being suppressed, ERα signaling remains active and plays a key role i...
Na minha lista:
| Publicado no: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7665895/ https://ncbi.nlm.nih.gov/pubmed/33112819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-20-0258 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|